Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings
article
OA: closed
CC0
⤵ 39 in-corpus citations
AI-generated summary
This study investigated aromatase expression in endometriotic tissues and its correlation with clinical and analytical findings.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo study the relationship between aromatase expression in endometriotic tissues and clinical and laboratory findings.DesignProspective basic and clinical research.SettingUniversity hospital.Patient(s)Sixty-two women with endometriosis, and 12 without endometriosis.Intervention(s)Conservative surgery, or hysterectomy and adnexectomy, along with an immunohistochemical study of aromatase in endometriotic and nonendometriotic tissues.Main outcome measure(s)Symptoms of the disease, ultrasound and surgical findings, values of tumor markers, steroids and immunoglobulins, and recurrences after surgery.Result(s)We observed positive immunohistochemical expression for aromatase in endometriotic tissues from 38 patients (61.3%). Aromatase expression was negative in the rest of the tissues studied and in the 12 cases without endometriosis. Aromatase-positive patients had a higher number of endometriomas, more bilaterality, and more moderate-to-severe chronic pelvic pain. Also, infertility and associated leiomyomas were more frequent in these patients, though without significant differences. There were no differences in recurrence of the disease 1 year later. Estradiol and PRL levels were significantly higher, and IgG values lower, than in aromatase-negative patients. High values of blood sedimentation rate were more frequent in aromatase-negative patients.Conclusion(s)Molecular alterations such as the presence of aromatase in endometriotic tissues could be involved in the development or maintenance of endometriosis. Our findings suggest major severity, activity, and chronic pelvic pain in patients with aromatase in endometriotic tissue.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- ABNORMAL LUTEAL FUNCTION IN PATIENT WITH ENDOMETRIOSIS via openalex
- A predictive model for endometriosis via openalex
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Aromatase expression in endometriosis. via openalex
- Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
- Aromatasehemmer - theoretisches Konzept und bisherige Erfahrungen in der Endometriosetherapie via openalex
- Aromatase in endometriosis and uterine leiomyomata via openalex
- Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: New questions—old answers? via openalex
- Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis via openalex
- CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists via openalex
- Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis via openalex
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex
- Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum via openalex
- GnRH Analogues, Transvaginal Ultrasound-Guided Drainage and Intracystic Injection of Recombinant Interleukin-2 in the Treatment of Endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Prolactin hyperstimulation in response to thyrotropin-releasing hormone in patients with endometriosis via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of Cytokines in Endometriosis-Associated Infertility via openalex
- THE GALACTORRHŒA-ENDOMETRIOSIS SYNDROME via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- W2135721067 via openalex
- W2111226394 via openalex
- W2074528669 via openalex
- W2069877703 via openalex
- W2299118357 via openalex
- W2047289419 via openalex
- W2477008945 via openalex
- W2586353586 via openalex
- W2029675056 via openalex
- W2017214509 via openalex
- W6656356435 via openalex
- W6668069468 via openalex
- W6681345756 via openalex
- W2158499144 via openalex
- W6814680148 via openalex
Cited by (38)
- Increased circulating T helper 17 (TH17) cells and endometrial tissue IL-17-producing cells in patients with endometriosis compared with non-endometriotic subjects 2025
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- Prolactin and pain of endometriosis 2023
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Aromatase Inhibitors Use for Endometriosis Patients 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Progesterone Resistance and Adult Stem Cells’ Genomic and Epigenetic Changes in the Puzzle of Endometriosis 2019
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial 2019
- SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis 2018
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis 2016
- Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model 2016
- Molecular Biology of Endometriosis 2016
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis 2015
- Epithelial Ovarian Cancers and Endometriosis 2015
- A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model 2015
- Role of Aromatase Inhibitors in the Treatment of Endometriosis 2014
- Systematic review of endometriosis pain assessment: how to choose a scale? 2014
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis 2014
- Chronic Pelvic Pain in Endometriosis: An Overview 2013
- Endometriosis: A Disease That Remains Enigmatic 2013
- The emerging use of aromatase inhibitors for endometriosis treatment 2011
- Are aromatase inhibitors effective in endometriosis treatment? 2011
- P450Arom induction in isolated control endometrial cells by peritoneal fluid from women with endometriosis 2010
- Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression 2010
- Expression of aromatase in endometiosis and its relation to clinical laboratory and surgical parameters 2010
- Molecular profiling of human endometrium and endometriosis 2010
- Is aromatase expression in the endometrium the cause of endometriosis and related infertility? 2009
- Expressão do gene da aromatase (CYP19A1) nas células da granulosa murais luteinizadas de mulheres com endometriose submetidas a técnicas de reprodução assistida 2009
- Absence of aromatase protein and mRNA expression in endometriosis 2009
- The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis 2008
- The Expression and Ovarian Steroid Regulation of Endometrial Micro-RNAs 2008
- Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy 2007
Source provenance
- europepmc
- last seen: 2026-09-07T06:12:11.729357+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:00.519696+00:00
- unpaywall
- last seen: 2026-09-07T06:27:18.705824+00:00
License: CC0
· commercial use OK